Management
A successful team beats with one heart
Management
Staffan Strömberg, Ph.D.
CEO since 2013. Born 1967.
Senior ExecutiveStaffan has over 20 years of experience in the pharmaceutical industry. Besides his role as Head of Medical Devices at the Swedish Medical Products Agency, he has also been Vice President of Nicox France, and had management positions at AstraZeneca. Staffan has particular experience in the development of orphan drugs as he was Head of R&D of Swedish Orphan Biovitrum AB (Sobi).
Shareholding in the Company: 51,873 shares of series B, 50,000 warrants 2020/2024, 120,000 warrants 2022/2025, 50,000 warrants 2023/2026, 50 000 warrants 2024/2027, and 55,037 shares of series B through the wholly-owned company Eteboxagu AB.
Anders Kronström, M.Sc., M.B.A.
Chief Operating Officer Since 2018. Born 1967.
Senior ExecutiveAnders Kronström has over 20 years of experience working in the pharmaceutical industry. His experience spans across all stages of drug development in different disease segments. During his career at AstraZeneca he has had senior leadership positions within Project Management and Business Development. More recently, he was a CEO of Biosergen AS, a Norwegian biotechnology company.
Shareholding in the Company: 11,194 shares of series B and 40,000 warrants 2020/2024, 75,000 warrants 2022/2025, 25,000 warrants 2023/2026, and 25,000 warrants 2024/2027.
Maria Ekdahl
Chief Financial Officer since 2022. Born 1973
Senior ExecutiveMaria, has a degree in economics from Linné University, has a solid financial background in both accounting and business controlling. She has experience from various organizations such as Telenor, Karolinska, Coca-Cola and the Swedish Film Institute.
Shareholding in the Company: 3,452 shares of series B, 25,000 warrants 2023/2026, and 25,000 warrants 2024/2027.
Thomas J. Schnitzer, MD, PhD
CHIEF SCIENTIFIC OFFICER
Dr. Schnitzer is a professor at Northwestern University Feinberg School of Medicine where he founded and directed the Office of Clinical Research and held the position of assistant dean for clinical research. He has advised numerous pharmaceutical and biotechnology companies, providing guidance in the design, conduct and analysis of clinical studies of novel drugs. He is a Master of the American College of Rheumatology, served on the editorial board of numerous journals, and has published over 200 peer-reviewed publications.
Professor Jonas Rastad, MD, Ph.D.
CHIEF MEDICAL OFFICER
Jonas has 20 years of experience in academic surgery and has published 250 papers in peer review journals. He has served in several managerial roles in AstraZeneca in Sweden, Japan, the UK and the US. He also has 13 years experience in senior public leadership roles including Head of County Hospital of Kalmar, Head of Västerbotten County Council and CEO of Region Skåne.